The differential diagnosis of pancreatic duct a ladenocarcinoma and pancreatic neuroendocrine tumors using 18F-FDG PET/CT combined with serum CA19-9,CEA and NSE

ZHENG Lichun; ZHANG Huan; GU Cheng; SHEN Xinyu; ZHANG Xiaoming; OUYANG Xiangliu

doi:10.3969/j.issn.1006-5725.2023.18.019

Home>Articles>The differential diagnosis of pancreatic duct a ladenocarcinoma and pancreatic neuroendocrine tumors using 18F-FDG PET/CT combined with serum CA19-9,CEA and NSE

DOI: 10.3969/j.issn.1006-5725.2023.18.019

The differential diagnosis of pancreatic duct a ladenocarcinoma and pancreatic neuroendocrine tumors using 18F-FDG PET/CT combined with serum CA19-9,CEA and NSE

ZHENG Lichun

ZHANG Huan

GU Cheng

SHEN Xinyu

ZHANG Xiaoming

OUYANG Xiangliu

Keywords：pancreatic ductal adenocarcinomapancreatic neuroendocrine tumorspositron emission to-mographyX ray computed tomography18F-deoxyglucosetumor marker

Publication Date：2023-09-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 2395-2400 )

The Journal of Practical Medicine

ISTICPKU

ISSN：1006-5725

Year, Vol.(Issue)：2023,39(18)